Eton Pharmaceuticals Inc (ETON)
3.62
-0.03
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Max Drawdown (5Y): 79.94% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 79.94% |
| March 31, 2024 | 79.94% |
| February 29, 2024 | 79.94% |
| January 31, 2024 | 79.94% |
| December 31, 2023 | 79.94% |
| November 30, 2023 | 79.94% |
| October 31, 2023 | 79.94% |
| September 30, 2023 | 79.94% |
| August 31, 2023 | 79.94% |
| July 31, 2023 | 79.94% |
| June 30, 2023 | 79.94% |
| May 31, 2023 | 79.94% |
| April 30, 2023 | 79.94% |
| March 31, 2023 | 79.94% |
| February 28, 2023 | 79.94% |
| January 31, 2023 | 79.94% |
| December 31, 2022 | 79.94% |
| November 30, 2022 | 79.94% |
| October 31, 2022 | 79.94% |
| September 30, 2022 | 79.74% |
| August 31, 2022 | 77.56% |
| July 31, 2022 | 74.68% |
| June 30, 2022 | 74.68% |
| May 31, 2022 | 71.30% |
| April 30, 2022 | 67.13% |
| Date | Value |
|---|---|
| March 31, 2022 | 67.13% |
| February 28, 2022 | 67.13% |
| January 31, 2022 | 67.13% |
| December 31, 2021 | 67.13% |
| November 30, 2021 | 67.13% |
| October 31, 2021 | 67.13% |
| September 30, 2021 | 67.13% |
| August 31, 2021 | 67.13% |
| July 31, 2021 | 67.13% |
| June 30, 2021 | 67.13% |
| May 31, 2021 | 67.13% |
| April 30, 2021 | 67.13% |
| March 31, 2021 | 67.13% |
| February 28, 2021 | 67.13% |
| January 31, 2021 | 67.13% |
| December 31, 2020 | 67.13% |
| November 30, 2020 | 67.13% |
| October 31, 2020 | 67.13% |
| September 30, 2020 | 67.13% |
| August 31, 2020 | 67.13% |
| July 31, 2020 | 67.13% |
| June 30, 2020 | 67.13% |
| May 31, 2020 | 67.13% |
| April 30, 2020 | 67.13% |
| March 31, 2020 | 67.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
14.37%
Minimum
May 2019
79.94%
Maximum
Oct 2022
66.39%
Average
67.13%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| Evoke Pharma Inc | 99.36% |
| Outlook Therapeutics Inc | 98.82% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -29.08 |
| Beta (5Y) | 1.186 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.37% |
| Historical Sharpe Ratio (5Y) | -0.2543 |
| Historical Sortino (5Y) | -0.4866 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.07% |